Predicting GLP-1 Discontinuation From Pharmacy Claims
Published: | Updated:
|Articles|September 1, 1998
Supplements and Featured Publications
- Clinical and Economic Considerations of Epilepsy and Its Medical Management
- Volume 4
- Issue 9 Suppl
Anticonvulsants: Choices and Costs
Author(s)Nina Graves, PharmD
Advertisement
Articles in this issue
about 28 years ago
Participating Facultyabout 28 years ago
Medical Management of Epilepsy: Issues and Implicationsabout 28 years ago
Demographics and Cost of Epilepsyabout 28 years ago
Care of Children With Epilepsyabout 28 years ago
Referral Centers and Specialized Careabout 28 years ago
Vagus Nerve Stimulationabout 28 years ago
Determining Costs and Cost-Effectiveness of Epilepsyabout 28 years ago
Selected Abstractsabout 28 years ago
CME Quizabout 28 years ago
BibliographyAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Multiagonists Outpace Older GLP-1 Drugs for Weight Loss
2
Physical Function Views Differ Between Older AML Patients, Clinicians
3
Evolocumab Cuts Death Risk for a First Heart Attack or Stroke
4
Better Cardiovascular Health Tied to Lower Overactive Bladder Risk
5